The subject of the public procurement contract is the supply and installation of a new, unused, non-refurbished, fully functional 1 unit of DNA sequencing analysis equipment, 1 unit of DNA fragmentation equipment, and 3 units of various servers (workstations).

The subject of performance consists of the following:

1. 1 unit of equipment for "massively" parallel sequencing analysis based on the principle of so-called long-read DNA sequencing, that is, DNA sequencing technology using long reads. This device will investigate regions, new genes, genetic variability, new structural variants, polynucleotide expansions, and regulatory elements that fall into the so-called "dark regions", i.e., inaccessible to existing short-read DNA technologies. It must be usable for research, diagnosis, and treatment of rare diseases within the European Reference Networks for rare and ultra-rare diseases and the international research network ERDERA.org.
2. 1 unit of equipment for controlled DNA fragmentation to a sample size of at least 5 to 100 kb, at a speed of at least 90 samples in 120 minutes.
3. 3 units of related computing equipment, i.e., servers for processing raw data from the device, a server for storing and backing up sequencing results and data analysis, and a workstation for bioinformatics analysis, optimized for collaboration with the aforementioned devices all according to the procurement documentation.

LOT-0001
UK2LF – Next Generation Sequencing Platform for Human Genome Analysis (hardware).
The subject of the public procurement contract is the supply and installation of a new, unused, non-refurbished, fully functional 1 unit of DNA sequencing analysis equipment, 1 unit of DNA fragmentation equipment, and 3 units of various servers (workstations).

The subject of performance consists of the following:

1. 1 unit of equipment for "massively" parallel sequencing analysis based on the principle of so-called long-read DNA sequencing, that is, DNA sequencing technology using long reads. This device will investigate regions, new genes, genetic variability, new structural variants, polynucleotide expansions, and regulatory elements that fall into the so-called "dark regions", i.e., inaccessible to existing short-read DNA technologies. It must be usable for research, diagnosis, and treatment of rare diseases within the European Reference Networks for rare and ultra-rare diseases and the international research network ERDERA.org.
2. 1 unit of equipment for controlled DNA fragmentation to a sample size of at least 5 to 100 kb, at a speed of at least 90 samples in 120 minutes.
3. 3 units of related computing equipment, i.e., servers for processing raw data from the device, a server for storing and backing up sequencing results and data analysis, and a workstation for bioinformatics analysis, optimized for collaboration with the aforementioned devices all according to the procurement documentation.